These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19451560)

  • 1. ACP Journal Club. Review: pneumococcal vaccination is not effective for preventing pneumonia, bacteremia, bronchitis, or mortality.
    Johnstone J
    Ann Intern Med; 2009 May; 150(10):JC5-4. PubMed ID: 19451560
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Pneumococcal vaccine reduced pneumococcal pneumonia and associated mortality.
    Fekete T
    Ann Intern Med; 2010 Jun; 152(12):JC6-5. PubMed ID: 20547899
    [No Abstract]   [Full Text] [Related]  

  • 3. Review: pneumococcal vaccination is not effective for preventing pneumonia, bacteraemia, bronchitis, or mortality.
    Johnstone J
    Evid Based Med; 2009 Aug; 14(4):109. PubMed ID: 19648425
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia.
    Musher DM; Rueda-Jaimes AM; Graviss EA; Rodriguez-Barradas MC
    Clin Infect Dis; 2006 Oct; 43(8):1004-8. PubMed ID: 16983612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.
    Simberkoff MS
    Semin Respir Infect; 1993 Dec; 8(4):294-9. PubMed ID: 7938926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.
    Fedson DS
    Semin Respir Infect; 1993 Dec; 8(4):285-93. PubMed ID: 7938925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACP Journal Club. Review: CURB65, CRB65, and Pneumonia Severity Index similarly predict mortality in community-acquired pneumonia.
    Morris A
    Ann Intern Med; 2011 Apr; 154(8):JC4-13. PubMed ID: 21502639
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries.
    Ament A; Baltussen R; Duru G; Rigaud-Bully C; de Graeve D; Ortqvist A; Jönsson B; Verhaegen J; Gaillat J; Christie P; Cifre AS; Vivas D; Loiseau C; Fedson DS
    Clin Infect Dis; 2000 Aug; 31(2):444-50. PubMed ID: 10987703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACP Journal Club. Review: Short-course antibiotics in hospital-acquired pneumonia do not affect mortality.
    Opal SM
    Ann Intern Med; 2012 Mar; 156(6):JC3-13. PubMed ID: 22431699
    [No Abstract]   [Full Text] [Related]  

  • 11. Pneumococcal bacteremia in Hawaii: initial findings of a pneumococcal disease prevention project.
    Campbell JF; Donohue MA; Mochizuki RB; Nevin-Woods CL; Spika JS
    Hawaii Med J; 1989 Dec; 48(12):513-4, 517-8. PubMed ID: 2635176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of pneumococcal vaccination--a prospective study in patients with longstanding emphysema and/or bronchitis.
    Franzen D
    Eur J Med Res; 2000 Dec; 5(12):537-40. PubMed ID: 11147998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACP Journal Club. Review: Inhaled corticosteroids do not reduce mortality but increase pneumonia in chronic obstructive pulmonary disease.
    Rees PJ
    Ann Intern Med; 2009 Mar; 150(6):JC3-6. PubMed ID: 19306488
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study.
    Vila-Corcoles A; Salsench E; Rodriguez-Blanco T; Ochoa-Gondar O; de Diego C; Valdivieso A; Hospital I; Gomez-Bertomeu F; Raga X
    Vaccine; 2009 Mar; 27(10):1504-10. PubMed ID: 19171174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.
    Fisman DN; Abrutyn E; Spaude KA; Kim A; Kirchner C; Daley J
    Clin Infect Dis; 2006 Apr; 42(8):1093-101. PubMed ID: 16575726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACP Journal Club. Review: Risk prediction scales have different strengths and weaknesses for predicting mortality in community-acquired pneumonia.
    Steinberg DI
    Ann Intern Med; 2011 Apr; 154(8):JC4-12. PubMed ID: 21502638
    [No Abstract]   [Full Text] [Related]  

  • 18. Pneumococcal vaccination and pneumonia: even a low level of clinical effectiveness is highly cost-effective.
    Ament A; Fedson DS; Christie P
    Clin Infect Dis; 2001 Dec; 33(12):2078-9. PubMed ID: 11700581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia.
    Kang CI; Song JH; Kim SH; Chung DR; Peck KR; Thamlikitkul V; Wang H; So TM; Hsueh PR; Yasin RM; Carlos CC; Van PH; Perera J
    J Infect; 2013 Jan; 66(1):34-40. PubMed ID: 22922634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and outcomes of older adults with community-acquired pneumococcal bacteremia.
    Chi RC; Jackson LA; Neuzil KM
    J Am Geriatr Soc; 2006 Jan; 54(1):115-20. PubMed ID: 16420207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.